Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9
Authors:
Open Access
- 26 February 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 29 (5) , 2046-2052
Abstract
MicroRNAs (miRs) play an important role in tumor initiation and progression in many types of cancer, including cholangiocarcinoma (CC). miR-138 dysregulation is frequently observed in a variety of tumors. In the present study, miR-138 was found to be downregulated in CC tissues by quantitative real-time RT-PCR. Furthermore, its potential target molecule, Ras homolog gene family, member C (RhoC) protein, was found to be highly expressed in CC tissues examined by western blot analysis. Luciferase reporter assay further demonstrated that miR-138 directly targeted RhoC. We found that the introduction of miR-138 mimics to RBE and QBC939 CC cells could reduced RhoC mRNA and protein expression, and suppressed the proliferation, G1/S transition, migration and invasion of CC cells. However, transfection with a miR-138 inhibitor induced an inverse effect in CC cells. The expression of phosphorylated extracellular signal-regulated kinase (p-ERK), matrix metalloproteinase (MMP)-2 and MMP-9 decreased following transfection with miR-138, and increased following transfection with miR-138 inhibitor in CC cells. In conclusion, RhoC upregulation induced by miR-138 downregulation promotes the malignant progression of CC cells and the underlying mechanisms of this effect involve the increase in the expression of p-ERK/MMP-2/MMP-9. Consequently, miR-138/RhoC is a potential target for the clinical diagnosis and treatment of CC.Keywords
This publication has 38 references indexed in Scilit:
- MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating β-cateninGastroenterology, 2012
- MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expressionGene, 2012
- Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinomaCell Cycle, 2012
- miR-25 Targets TNF-Related Apoptosis Inducing Ligand (TRAIL) Death Receptor-4 and Promotes Apoptosis Resistance in CholangiocarcinomaHepatology, 2011
- The role of microRNA expression pattern in human intrahepatic cholangiocarcinomaJournal of Hepatology, 2009
- MicroRNA Profiling of Human Intrahepatic Cholangiocarcinoma Cell Lines Reveals Biliary Epithelial Cell-specific MicroRNAsJournal of Nippon Medical School, 2009
- Multi-disciplinary treatment for cholangiocellular carcinomaWorld Journal of Gastroenterology, 2007
- Advances in the diagnosis, evaluation and management of cholangiocarcinomaCurrent Opinion in Gastroenterology, 2006
- Current approaches to the diagnosis and treatment of cholangiocarcinomaCurrent Gastroenterology Reports, 2006
- CholangiocarcinomaNature Clinical Practice Gastroenterology & Hepatology, 2006